Hormone and Metabolic Research
Our clients achieve their weight loss goals and experience improved energy, confidence, and overall quality of life
(FDA approvals of Wegovy for cardiovascular disease and Zepbound for sleep apnea occurred in 2024 and therefore these uses are likely not reflected in Part D data through 2024.) More than half of gross spending in 2024 was on semaglutide products (Ozempic, 47%
The clearest signal comes straight from FDA prescribing information for semaglutide products, which notes that there have been postmarketing reports of acute kidney injury, in some cases requiring hemodialysis
Some customers reported serious illness after injections, and authorities in multiple states are investigating related complaints
Smart Scale Renpho Smart Scale Using a smart scale is incredibly helpful on a GLP-1 journey, as it enables you to track your body composition over time. Products like the Renpho Smart Scale provide data beyond a simple weight measurement, including skeletal muscle mass, body fat percentage, and visceral fat (the fat around your organs)